Monolithic Power Systems reported quarterly earnings of $4.21 per share which beat the analyst consensus estimate of $4.11 ...

After relocating from Portland, Oregon, to a medium-cost-of-living city, one engineer and his wife thought they’d made a ...

LENZ Therapeutics' VIZZ earns FDA approval as the first aceclidine-based eye drop to treat presbyopia, with U.S. launch expected in Q4 2025.

European shares were lower today. The eurozone's STOXX 600 fell 2%, while Spain's IBEX 35 Index dipped 2.1%. London's FTSE ...

Analysts expect Tyson Foods to report an earnings per share (EPS) of $0.76. The market awaits Tyson Foods's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance ...

Analysts have given Encompass Health a total of 2 ratings, with the consensus rating being Outperform. The average one-year ...

Analysts anticipate IDEXX Laboratories to report an earnings per share (EPS) of $3.30. The announcement from IDEXX ...

Armada AI, another San Francisco-based startup, raised $131 million in a round led by Marlinspike Capital and Felicis ...

A total of 9 analyst ratings have been received for MercadoLibre, with the consensus rating being Outperform. The average one-year price target stands at $2952.78, suggesting a potential 24.39% upside ...

Return on Equity (ROE): Waters's ROE stands out, surpassing industry averages. With an impressive ROE of 6.4%, the company demonstrates effective use of equity capital and strong financial performance ...

Simon Property Group has received a total of 7 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $183.86, the consensus suggests a potential 12.25% ...

Return on Equity (ROE): Palantir Technologies's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 4.11%, the company may face ...